Paid Clinical Trials Gainesville

Discover 619 paid clinical trials in Gainesville, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 619

Training Response Artificial Intelligence Network (TRAIN)Training Response Artificial Intelligence Network (TRAIN)

Recruiting

Sponsor:

University of Florida

Location:

Gainesville FL

Code:

NCT05903573

Conditions

Amnestic Mild Cognitive Impairment

Eligibility Criteria

Sex: All

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

Cognitive Training

Computerized Cognitive Stimulation

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic EsophagitisEfficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Inverness FL, Jacksonville FL, Saint Augustine FL, Atlanta GAshow 30 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver FibrosisStudy to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis

Recruiting

PHASE2

Sponsor:

Kowa Research Institute, Inc.

Location:

Ocala FL, Inverness FL, Jacksonville FL, Ocoee FLshow 42 more

Code:

NCT05327127

Conditions

NASH

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

K-877-ER

CSG452

Placebo

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine GliomaA Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Recruiting

PHASE1

Sponsor:

Pediatric Brain Tumor Consortium

Location:

Gainesville FL, Atlanta GA, Cincinnati OH, Washington DCshow 8 more

Code:

NCT04978727

Conditions

Medulloblastoma

Glioblastoma Multiforme

Anaplastic Astrocytoma

High-grade Astrocytoma NOS

Anaplastic Oligodendroglioma

Eligibility Criteria

Sex: All

Age: 1 - 21

Healthy Volunteers: Not accepted

Interventions

SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years

SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥1 and <10 years

SurVaxM for patients with non-relapsed DIPG post radiation-therapy ages ≥1 and ≤21 years

Apraxia in Parkinson's Disease Patients With Deep Brain StimulationApraxia in Parkinson's Disease Patients With Deep Brain Stimulation

Recruiting

Sponsor:

University of Florida

Location:

Gainesville FL

Code:

NCT04725773

Conditions

Deep Brain Stimulation

Parkinson Disease

Apraxia, Motor

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Deep brain stimulation effect on apraxia

To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsTo Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

Recruiting

PHASE3

Sponsor:

Cerevance

Location:

Ocala FL, Port Orange FL, Maitland FL, Orlando FLshow 20 more

Code:

NCT06553027

Conditions

Parkinson Disease

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

CVN424 75 mg

CVN424 150 mg

Placebo

Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyImpact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

Recruiting

Sponsor:

Dennis M. McNamara, MD, MS

Location:

Gainesville FL, Jacksonville FL, Tampa FL, Charleston SCshow 48 more

Code:

NCT05180773

Conditions

Peripartum Cardiomyopathy, Postpartum

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bromocriptine

Placebo

Guideline Directed Medical Therapy for Heart Failure (GDMT)

Rivaroxaban

Second Placebo

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking AbilityTesting if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Recruiting

PHASE3

Sponsor:

NRG Oncology

Location:

Gainesville FL, Wesley Chapel FL, Tampa FL, Savannah GAshow 156 more

Code:

NCT04804644

Conditions

Metastatic Lung Small Cell Carcinoma

Metastatic Malignant Neoplasm in the Brain

Recurrent Lung Small Cell Carcinoma

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Magnetic Resonance Imaging

Memantine Hydrochloride

Neurocognitive Assessment

Stereotactic Radiosurgery

A Study to Access the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)A Study to Access the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)

Recruiting

PHASE3

Sponsor:

Axsome Therapeutics, Inc.

Location:

Gainesville FL, Jacksonville FL, Orlando FL, Palm Bay FLshow 34 more

Code:

NCT05972044

Conditions

ADHD

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Solriamfetol 150 mg

Solriamfetol 300 mg

Placebo

To Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLCTo Evaluate Efficacy and Safety of Serplulimab + Chemotherapy (Carboplatin- Etoposide) in US Patients With ES-SCLC

Recruiting

PHASE3

Sponsor:

Shanghai Henlius Biotech

Location:

Ocala FL, Jacksonville FL, Brooksville FL, Orange City FLshow 85 more

Code:

NCT05468489

Conditions

Extensive Stage Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Serplulimab + chemotherapy (carboplatin-etoposide)

Atezolizumab + chemotherapy (carboplatin-etoposide)